Please login to the form below

Not currently logged in
Email:
Password:

Biotech profile

This page shows the latest Biotech profile news and features for those working in and with pharma, biotech and healthcare.

Sanofi set to acquire Kiadis for €308m

Sanofi set to acquire Kiadis for €308m

Acquisition will see French pharma gain access to NK-cell platform. French pharma Sanofi is set to buy Kiadis for a total of 308 ($358m) for access to the biotech’s ... We believe this transaction represents compelling value to shareholders and offers

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    Tom Evans. Pharma Market Europe talks to its chief executive Tom Evans, a veteran research and business leader in viral diseases, with experience across academia, big pharma and biotech. ... potential to fulfil this target profile.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines. ... and sustainable clinical pipeline and a robust product engine by the end of 2020; a company profile rarely, if ever, achieved in

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

There’s Comfort in Consistency
Campaigns take time to bed in and be exposed. I’m sure it must be reassuring for HCPs to identify their favoured product through an easily identifiable image or message –...
What does HCP engagement look like in a post-Covid world?
HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...
Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....